Abstract
The activities of recombinant interleukin-1-β (IL-1) and recombinant tumor necrosis factor-α (TNF) on cartilage proteoglycan metabolism were compared in an organ culture system. IL-1, 1 to 100 ng/ml, and TNF, 10 to 1,000 ng/ml, increased proteoglycan degradation. The concentration-response curves were parallel. The timecourse for degradation was similar for the two cytokines during a 6 day incubation. Both cytokines inhibited the synthesis of new proteoglycan as measured by35S incorporation. The inhibition curves were parallel and concentration-related between 1 and 10 ng/ml for IL-1 and between 10 and 100 ng/ml for TNF. Maximal inhibition was 60% in the presence of IL-1 (10 ng/ml) or TNF (100 ng/ml), and plateaued at higher concentrations. IL-1 was ten fold more potent than TNF in stimulating proteoglycan breakdown and inhibiting proteoglycan synthesis. Degradation in response to TNF, but not to IL-1, could be blocked by a polyclonal antibody to TNF. A polyclonal antibody to IL-1 could block proteoglycan breakdown in response to both cytokines suggesting that TNF may be mediating proteoglycan degradation by inducing the production of interleukin-1.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. W. Larrick and S. L. Kunkel,The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response. Pharmaceutical Research5, 129–139 (1988).
J. Saklatvala,Tumor necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature322, 547–549 (1986).
J. J. Huang, R. C. Newton, K. Pezzella, M. Covington, T. Tamblyn, S. J. Rutledge, M. Kelley, J. Gray and Y. Lin,High level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1-β. Mol. Biol. Med.4, 169–181 (1987).
E. C. Arner, L. R. Darnell, M. A. Pratta, R. C. Newton, N. R. Ackerman and W. Galbraith,Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation. Agents and Actions21, 334–336 (1987).
P. P. Naworth, I. Bank, D. Handley, J. Cassimeris, L. Chess and D. Stern,Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med.163, 1363–1375 (1986).
C. A. Dinarello, J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino Jr. and J. V. O'Conner,Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1, J. Exp. Med.163, 1433–1450 (1986).
N. C. Rath, A. L. Oronsky and S. S. Kerwar,Synthesis of interleukin-1-like activity by normal rat chondrocytes in culture. Clinical Immunology and Immunopathology47, 39–46 (1988).
F. M. Ollivierre, U. Gubler, H. J. Mankin and B. V. Treadwell,Chondrocytes synthesize interleukin-1. Transactions of the 33rd Annual Meeting of the Orthopaedic Research Society12, 422 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pratta, M.A., Di Meo, T.M., Ruhl, D.M. et al. Effect of interleukin-1-β and tumor necrosis factor-α on cartilage proteoglycan metabolismin vitro . Agents and Actions 27, 250–253 (1989). https://doi.org/10.1007/BF01972788
Issue Date:
DOI: https://doi.org/10.1007/BF01972788